Investigating new ways to improve T cell therapies for pancreatic cancer
Project 2
This study is looking at a tough type of pancreatic cancer to find out how its unique environment makes it hard for treatments to work, and it aims to improve a type of therapy that uses special immune cells to better fight the cancer and help patients feel better.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10896031 on NIH RePORTER |
What this research studies
This research focuses on pancreatic ductal adenocarcinoma, a highly aggressive cancer with very low survival rates. It aims to understand the unique fibrotic and immunosuppressive environment of pancreatic tumors that hinders effective treatment. By using advanced imaging and mathematical modeling, the research seeks to enhance the ability of engineered T cells to infiltrate and function within these tumors. The goal is to develop improved strategies for adoptive cellular immunotherapy that can lead to better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.
Not a fit: Patients with other types of cancer or those who are not diagnosed with pancreatic ductal adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in enhancing T cell therapies for other cancers, but this approach is particularly novel for pancreatic cancer.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Provenzano, Paolo — University of Minnesota
- Study coordinator: Provenzano, Paolo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.